|Articles|January 1, 2005

Parent guide: A guide to sports participation after brain injury (PDF)

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Related Content

FDA approves powder formulation of trofinetide for Rett syndrome

ByMorgan Ebert, Managing Editor,Joshua Fitch, Senior Editor

December 12th 2025

Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

ByJoshua Fitch, Senior Editor ,Jonathan Strober, MD

November 26th 2025

FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy

ByMorgan Ebert, Managing Editor

November 25th 2025

FDA grants 510(k) clearance for Clarity algorithm to detect electrographic seizures in newborns

ByJoshua Fitch, Senior Editor

November 24th 2025

Pushing boundaries for developmental and epileptic encephalopathy, with Olivia Kim-McManus, MD

ByOlivia Kim-McManus, MD

November 18th 2025

Latest CME

In-Person + Virtual Event

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

January 23, 2026

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Parent guide: A guide to sports participation after brain injury (PDF)

Newsletter

Related Content

FDA approves powder formulation of trofinetide for Rett syndrome

Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy

FDA grants 510(k) clearance for Clarity algorithm to detect electrographic seizures in newborns

Pushing boundaries for developmental and epileptic encephalopathy, with Olivia Kim-McManus, MD

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

FDA approves Nuzolvence (zoliflodacin) for treatment of uncomplicated urogenital gonorrhea in 12 years and up

Edward Hook, MD, reacts to the FDA approval of zoliflodacin for uncomplicated urogenital gonorrhea

Full case: A slender teen with a growing abdomen and shrinking height velocity

FDA approves gepotidacin as oral treatment for urogenital gonorrhea

Reports: FDA launching safety review of nirsevimab and clesrovimab for RSV